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Background:  Left ventricular late gadolinium enhancement (LV-LGE) provides prognostic information in patients with coronary artery disease, 
ischemic and nonischemic cardiomyopathies. Recently, the incidental LV-LGE on cardiac magnetic resonance (CMR) in atrial fibrillation (AF) patients 
has been associated with mortality. However, the data of LV-LGE on the clinical significance in AF is still limited. We aimed to evaluate the prognostic 
value of this incidental finding for AF recurrence after ablation therapy.
Methods:  Between June 2006 and January 2013, 778 patients referred for radiofrequency ablation of AF underwent CMR exams. 16 patients (2%) 
with history or clinical evidence of prior MI and 116 patients (15%) with no AF ablation therapy were excluded. All LGE MRI scans were evaluated by 
two experienced readers. The endpoint of interest was AF recurrence after ablation therapy determined by retrospective review of electronic medical 
records. Univariate and multivariate analysis were performed to identify predictors of AF recurrence after ablation therapy.
results:  Total of 646 patients who underwent ablation therapy were included in the study. In this patient cohort, 61% were male with an average 
age of 64 years and a median AF duration of 25 months. LV-LGE was found in 49 (8%) patients. There were 226 AF recurrences after ablation therapy 
over a median follow up period of 50 months. On univariable analysis, hypertension (HR 1.49, CI 1.041-2.124, p = 0.029) and presence of LV-LGE 
(HR 1.6, CI 1.217-2.114, p = 0.0036) provided the strong association with AF recurrence. The AF recurrent rate was 45% in patients who had an 
incidental LV-LGE compared to 34% in patients without this finding (p= 0.004). In multivariate analysis, the presence of LV-LGE was independent 
predictor of AF recurrence after ablation therapy.
conclusions:  In this large cohort of AF patients without a history of MI, incidental finding of LV-LGE is shown to be an independent predictor of AF 
recurrence after ablation therapy. These results further reiterate the role of LGE-MRI in deciding the suitability of ablation therapy in AF patients.
